Legal Name: OPALEYE MANAGEMENT INC.
報告期間:
Jun 30, 2019
有効日:
Aug 14, 2019
セキュリティ |
保有株式/元本 |
市場価格 |
オプション |
Codexis Inc (192005106)
|
1,350,000 |
$24,881k |
|
HARROW HEALTH (45323A201)
|
2,210,000 |
$19,227k |
|
AXOGEN INC COM (05463X106)
|
900,000 |
$17,820k |
|
EPIZYME INC (29428V104)
|
1,365,000 |
$17,131k |
|
UNIQURE N.V. (N90064101)
|
205,000 |
$16,021k |
|
ODONATE THERAPEUTICS INC (676079106)
|
425,000 |
$15,593k |
|
OCULAR THERAPEUTIX INC (67576A100)
|
2,950,000 |
$12,980k |
|
B. Riley Wealth Management, Inc. (023111206)
|
645,000 |
$12,507k |
|
BLUEPRINT MEDICINES CORP (09627Y109)
|
125,000 |
$11,791k |
|
CERECOR INC (15671L109)
|
2,185,536 |
$11,176k |
|
AUDENTES THERAPEUTICS INC COM (05070R104)
|
280,000 |
$10,601k |
|
PTC THERAPEUTICS INC (69366J200)
|
226,388 |
$10,187k |
|
CYTOKINETICS (23282W905)
|
900,000 |
$10,125k |
|
TG THERAPEUTICS INC (88322Q108)
|
1,150,000 |
$9,948k |
|
EIDOS THERAPEUTICS INC (28249H104)
|
305,550 |
$9,496k |
|
LEXICON PHARMACUTICL (528872302)
|
1,480,000 |
$9,309k |
|
Eton Pharmaceuticals, Inc. (29772L108)
|
1,075,000 |
$8,493k |
|
MAGENTA THERAPEUTICS INC COM (55910K108)
|
535,000 |
$7,891k |
|
TRICIDA INC (89610F101)
|
195,000 |
$7,695k |
|
DECIPHERA PHARMACEUTICALS IN (24344T101)
|
310,000 |
$6,991k |
|
FIBROGEN INC (31572Q808)
|
150,000 |
$6,777k |
|
BIOHAVEN PHARMACTL HLDG CO L (G11196105)
|
150,000 |
$6,569k |
|
CHIMERIX INC (16934W106)
|
1,470,000 |
$6,350k |
|
XOMA CORP DEL (98419J206)
|
400,000 |
$5,944k |
|
AVENUE THERAPEUTICS INC (05360L205)
|
930,000 |
$5,859k |
|
IRONWOOD PHARMACEUCL (46333X108)
|
525,400 |
$5,748k |
|
ACADIA PHARMACEUTCLS (004225108)
|
200,000 |
$5,346k |
|
ARVINAS INC (04335A105)
|
220,000 |
$4,838k |
|
Vermillon Inc. (92407M206)
|
4,250,000 |
$3,783k |
|
ZYMEWORKS INC (98985W102)
|
170,000 |
$3,744k |
|
STRONGBRIDGE BIOPHARMA PLC (G85347105)
|
1,140,000 |
$3,568k |
|
FORTRESS BIOTECH INC (034960Q19)
|
2,365,000 |
$3,548k |
|
VIKING THERAPEUTICS INC COM (92686J106)
|
400,000 |
$3,320k |
|
AIMMUNE THERAPEUTICS INC (00900T107)
|
130,000 |
$2,708k |
|
AQUESTIVE THERAPEUTICS INC (03843E104)
|
590,000 |
$2,478k |
|
SYNTHORX INC (87167A103)
|
157,600 |
$2,129k |
|
RA PHARMACEUTICALS (74933V108)
|
51,000 |
$1,534k |
|
FENNEC PHARMACEUTICALS (31447P100)
|
295,000 |
$1,180k |
|
ARQULE INC (04269E107)
|
100,000 |
$1,101k |
|
CRINETICS PHARMACE (22663K107)
|
36,000 |
$900k |
|
PROTALIX BIOTHERAPEUTICS INC (74365A101)
|
1,000,000 |
$469k |
|
AZURRX BIOPHARMA INC COM (05502L105)
|
145,000 |
$247k |
|
BIOLINERX LTD (09071M106)
|
250,000 |
$91k |
|